Evidence map›Paper›PMID 34073536›Full record

ArticleDiagnostics (Basel, Switzerland)2021

COVID-19 Vaccine and Death: Causality Algorithm According to the WHO Eligibility Diagnosis.

Cristoforo Pomara, Francesco Sessa, Marcello Ciaccio, Francesco Dieli, Massimiliano Esposito, Giovanni Maurizio Giammanco, Sebastiano Fabio Garozzo, Antonino Giarratano, Daniele Prati, Francesca Rappa and 4 more

Abstract read
In one paragraph

Article in Diagnostics (Basel, Switzerland), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 46 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
46citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

46 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Review
  16. Post-COVID-19 Vaccination CNS Magnetic Resonance Imaging Findings: A Systematic Review.The Canadian journal of infectious diseases & medical microbiology = Journal canadien des maladies infectieuses et de la microbiologie medicale · 2023
    Review
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Cristoforo PomaraDepartment of Medical, Surgical and Advanced Technologies "G.F. Ingrassia", University of Catania, 95121 Catania, Italy.ORCID 0000-0002-9895-3402
Francesco SessaDepartment of Clinical and Experimental Medicine, University of Foggia, 71122 Foggia, Italy.ORCID 0000-0003-0357-8791
Marcello CiaccioClinical Molecular Medicine and Laboratory Medicine, Institute of Clinical Biochemistry, Department of Biomedicine, Neurosciences and Advanced Diagnostics, University of Palermo, 90127 Palermo, Italy.ORCID 0000-0001-6120-9041
Francesco DieliCentral Laboratory of Advanced Diagnosis and Biomedical Research (CLADIBIOR), University of Palermo, 90128 Palermo, Italy.ORCID 0000-0002-6685-352X
Massimiliano EspositoDepartment of Medical, Surgical and Advanced Technologies "G.F. Ingrassia", University of Catania, 95121 Catania, Italy.ORCID 0000-0001-7880-3450
Giovanni Maurizio GiammancoDepartment of Health Promotion, Mother and Child Care, Internal Medicine and Medical Specialties (Pro.M.I.S.E.), University of Palermo, 90128 Palermo, Italy.ORCID 0000-0002-7874-6289
Sebastiano Fabio GarozzoClinical Pathology Unit, Garibaldi Centro Hospital, ARNAS Garibaldi, 95121 Catania, Italy.
Antonino GiarratanoDepartment of Surgical, Oncological and Oral Science (Di.Chir.On.S.), University of Palermo, 90128 Palermo, Italy.
Daniele PratiFondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Department of Transfusion Medicine and Hematology, 20162 Milan, Italy.
Francesca RappaDepartment of Biomedicine and Neurosciences and Advanced Diagnostics, University of Palermo, 90127 Palermo, Italy.ORCID 0000-0001-6610-5268
Monica SalernoDepartment of Medical, Surgical and Advanced Technologies "G.F. Ingrassia", University of Catania, 95121 Catania, Italy.
Claudio TripodoTumor Immunology Unit, Department of Health Sciences, Human Pathology Section, University of Palermo School of Medicine Palermo, 90128 Palermo, Italy.ORCID 0000-0002-1915-3897
Pier Mannuccio MannucciFondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Angelo Bianchi Bonomi Hemophilia and Thrombosis Center, 20162 Milan, Italy.
Paolo ZamboniHub Center for Venous and Lymphatic Diseases Regione Emilia-Romagna, Sant'Anna University Hospital of Ferrara, 44124 Ferrara, Italy.ORCID 0000-0002-7107-888X

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The current challenge worldwide is the administration of anti-severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccines. Even if rarely, severe vascular adverse reactions temporally related to vaccine administration have induced diffidence in the population at large. In particular, researchers worldwide are focusing on the so-called "thrombosis and thrombocytopenia after COVID-19 vaccination". This study aims to establish a practical workflow to define the relationship between adverse events following immunization (AEFI) and COVID-19 vaccination, following the basic framework of the World Health Organization (WHO). Post-mortem investigation plays a pivotal role to support this causality relationship when death occurs. To demonstrate the usefulness and feasibility of the proposed workflow, we applied it to two exemplificative cases of suspected AEFI following COVID-19 vaccination. Based on the proposed model, we took into consideration any possible causality relationship between COVID-19 vaccine administration and AEFI. This led us to conclude that vaccination with ChAdOx1 nCov-19 may cause the rare development of immune thrombocytopenia mediated by platelet-activating antibodies against platelet factor 4 (PF4), which clinically mimics heparin-induced autoimmune thrombocytopenia. We suggest the adoption of the proposed methodology in order to confirm or rule out a causal relationship between vaccination and the occurrence of AEFI.

Indexed as

autopsyCOVID-19deep vein thrombosisdisseminated intravascular coagulationimmune thrombocytopeniapost-mortem investigationSARS-CoV-2standard protocolvaccination campaignvaccine

Identifiers

PMID34073536
PMCPMC8229116

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.